Portal de Periódicos da CAPES

Nanoflowers: a future therapy for cardiac and ischemic disease?

2013; Future Medicine; Volume: 8; Issue: 11 Linguagem: Inglês

10.2217/nnm.13.161

1748-6963

Chitta Ranjan Patra, Ayan Kumar Barui,

Aortic aneurysm repair treatments

NanomedicineVol. 8, No. 11 EditorialNanoflowers: a future therapy for cardiac and ischemic disease?Chitta Ranjan Patra & Ayan Kumar BaruiChitta Ranjan Patra* Author for correspondenceBiomaterials Group, CSIR-Indian Institute of Chemical Technology, Uppal Road, Tarnaka, Hyderabad 500007, AP, India. & Ayan Kumar BaruiBiomaterials Group, CSIR-Indian Institute of Chemical Technology, Uppal Road, Tarnaka, Hyderabad 500007, AP, India.Published Online:24 Oct 2013https://doi.org/10.2217/nnm.13.161AboutSectionsView ArticleView Full TextPDF/EPUB ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareShare onFacebookTwitterLinkedInRedditEmail View articleKeywords: angiogenesiscardiovascular diseasenanoflowerreactive oxygen specieszinc oxideReferences1 DevezaL, Choi J, Yang F. Therapeutic angiogenesis for treating cardiovascular diseases. Theranostics2(8),801–814 (2012).Crossref, Medline, Google Scholar2 Finegold JA, Asaria P, Francis DP. Mortality from ischaemic heart disease by country, region, and age: statistics from World Health Organisation and United Nations. Int. J. Cardiol. doi:10.1016/j.ijcard.10.046 (2012) (Epub ahead of print).Google Scholar3 Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med.3(11),e442(2006).Crossref, Medline, Google Scholar4 Smith SC Jr, Allen J, Blair SN et al. AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: endorsed by the National Heart, Lung, and Blood Institute. Circulation113(19),2363–2372 (2006).Crossref, Medline, Google Scholar5 Dvorak HF. Angiogenesis: update 2005. J. Thromb. Haemost.3(8),1835–1842 (2005).Crossref, Medline, CAS, Google Scholar6 Jacobs J. Combating cardiovascular disease with angiogenic therapy. Drug Discov. Today12(23–24),1040–1045 (2007).Crossref, Medline, CAS, Google Scholar7 Folkman J. Tumor angiogenesis: therapeutic implications. N. Engl. J. Med.285(21),1182–1186 (1971).Crossref, Medline, CAS, Google Scholar8 Kalka C, Takahashi T, Masuda H, Asahara T, Isner JM. Vascular endothelial factor (VEGF): therapeutic angiogenesis and vasculogenesis in the treatment of cardiovascular disease. Med. Klin. (Munich)94(4),193–201 (1999).Crossref, Medline, CAS, Google Scholar9 Alivisatos P. The use of nanocrystals in biological detection. Nat. Biotech.22(1),47–52 (2004).Crossref, Medline, CAS, Google Scholar10 Medintz IL, Uyeda HT, Goldman ER, Mattoussi H. Quantum dot bioconjugates for imaging, labelling and sensing. Nat. Mat.4(6),435–446 (2005).Crossref, Medline, CAS, Google Scholar11 Patra CR, Bhattacharya R, Patra S et al. Pro-angiogenic properties of europium(III) hydroxide nanorods. Adv. Mater.20(4),753–756 (2008).Crossref, CAS, Google Scholar12 Patra CR, Kim JH, Pramanik K et al. Reactive oxygen species driven angiogenesis by inorganic nanorods. Nano. Lett.11(11),4932–4938 (2011).Crossref, Medline, CAS, Google Scholar13 Barui AK, Veeriah V, Mukherjee S et al. Zinc oxide nanoflowers make new blood vessels. Nanoscale4(24),7861–7869 (2012).Crossref, Medline, CAS, Google Scholar14 Patra CR, Abdel Moneim SS, Wang E et al.In vivo toxicity studies of europium hydroxide nanorods in mice. Toxicol. Appl. Pharmacol.240(1),88–98 (2009).Crossref, Medline, CAS, Google Scholar15 Chaudhuri P, Harfouche R, Soni S et al. Shape effect of carbon nanovectors on angiogenesis. ACS Nano4(1),574–582 (2010).Crossref, Medline, CAS, Google Scholar16 Ayhanci A, Uyar R, Aral E et al. Protective effect of zinc on cyclophosphamide-induced hematoxicity and urotoxicity. Biol. Trace Elem. Res.126(1–3),186–193 (2008).Crossref, Medline, CAS, Google Scholar17 Muller KH, Kulkarni J, Motskin M et al. pH-dependent toxicity of high aspect ratio ZnO nanowires in macrophages due to intracellular dissolution. ACS Nano4(11),6767–6779 (2010).Crossref, Medline, CAS, Google Scholar18 Li Z, Yang RS, Yu M et al. Cellular level biocompatibility and biosafety of ZnO nanowires. J. Phys. Chem.112(51),20114–20117 (2008).Crossref, CAS, Google Scholar19 Paek HJ, Lee YJ, Chung HE et al. Modulation of the pharmacokinetics of zinc oxide nanoparticles and their fates in vivo. Nanoscale doi:10.1039/c3nr02140h (2013) (Epub ahead of print).Google Scholar20 Kim J, Cao L, Shvartsman D, Silva EA, Mooney DJ. Targeted delivery of nanoparticles to ischemic muscle for imaging and therapeutic angiogenesis. Nano. Lett.11(2),694–700 (2011).Crossref, Medline, CAS, Google Scholar101 MarketResearch. www.marketresearch.comGoogle ScholarFiguresReferencesRelatedDetailsCited ByApplication of zinc oxide nanoflowers in environmental and biomedical scienceBBA Advances, Vol. 2HtrA3‐Mediated Endothelial Cell–Extracellular Matrix Crosstalk Regulates Tip Cell Specification24 May 2021 | Advanced Functional Materials, Vol. 31, No. 30Mechanisms underlying the anticancer applications of biosynthesized nanoparticlesPotential Therapeutic Application of Zinc Oxide Nanoflowers in the Cerebral Ischemia Rat Model through Neuritogenic and Neuroprotective Properties12 February 2020 | Bioconjugate Chemistry, Vol. 31, No. 3Recent Development of Metal Nanoparticles for Angiogenesis Study and Their Therapeutic Applications18 October 2019 | ACS Applied Bio Materials, Vol. 2, No. 12Engineered Nanoparticles for Effective Redox Signaling During Angiogenic and Antiangiogenic TherapyAntioxidants & Redox Signaling, Vol. 30, No. 5Nanocardiology21 March 2017Biomedical and drug delivery applications of functionalized inorganic nanomaterialsGreen synthesis of silver nanoparticles via plant extracts: beginning a new era in cancer theranosticsMuhammad Ovais, Ali Talha Khalil, Abida Raza, Muhammad Adeeb Khan, Irshad Ahmad, Nazar Ul Islam, Muthupandian Saravanan, Muhammad Furqan Ubaid, Muhammad Ali & Zabta Khan Shinwari4 November 2016 | Nanomedicine, Vol. 11, No. 23Insight into Biological Effects of Zinc Oxide Nanoflowers on Bacteria: Why Morphology Matters12 April 2016 | ACS Applied Materials & Interfaces, Vol. 8, No. 16Graphene oxides and the angiogenic processChitta Ranjan Patra30 September 2015 | Nanomedicine, Vol. 10, No. 19Biosynthesized silver nanoparticles: a step forward for cancer theranostics?Chitta Ranjan Patra, Sudip Mukherjee & Rajesh Kotcherlakota25 September 2014 | Nanomedicine, Vol. 9, No. 10 Vol. 8, No. 11 Follow us on social media for the latest updates Metrics Downloaded 105 times History Published online 24 October 2013 Published in print November 2013 Information© Future Medicine LtdKeywordsangiogenesiscardiovascular diseasenanoflowerreactive oxygen specieszinc oxideFinancial & competing interests disclosureThis research was supported by the Ramanujan Fellowship grant (SR/S2/RJN-04/2010; GAP0305), DST–New Delhi and generous financial support by Council of Scientific and Industrial Research – Mayo Clinic Collaboration for Innovation and Translational Research (MLP0020) to CR Patra. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.No writing assistance was utilized in the production of this manuscript.PDF download